POS0266 CYCLING VS SWAP TNFi AND IL17i IN PSORIATIC ARTHRITIS: RESULTS FROM THE BIRRA RETROSPECTIVE OBSERVATIONAL STUDY

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1POS0278 COMPARISON OF CYCLE VERSUS SWAP TREATMENT STRATEGY ON DRUG RETENTION AND DISEASE ACTIVITY AFTER TNFi FAILURE IN PSORIATIC ARTHRITIS: A QUASI-EXPERIMENTAL STUDY2024
2. 2POS0259 DOES BIOLOGIC DMARD RETENTION IN AXIAL PSORIATIC ARTHRITIS DEPEND ON THE MODE OF ACTION? COMPARISON OF TNF, IL-17, AND IL-23 INHIBITORS IN A LARGE OBSERVATION COHORT2024
3. 3LBA0002 EARLY (3-MONTH) AND MAINTAINED (12-MONTH) COMPARATIVE EFFECTIVENESS OF 5 DIFFERENT CLASSES OF ADVANCED THERAPIES IN A LARGE MULTINATIONAL COHORT OF REAL-WORLD PSA PATIENTS2024
4. 4POS0478 SURVIVALTO b/tsDMARDs IN PATIENTS AFTER FULFILLING DIFFICULT-TO-TREAT RHEUMATOID ARTHRITIS CLASSIFICATION2024
5. 5P182 Real-world comparative effectiveness of upadacitinib in psoriatic arthritis: evaluation of switching to upadacitinib versus tumor necrosis factor inhibitors or interleukin-17 inhibitors after first-line tumor necrosis factor inhibitors2026